Evidence map›Paper›PMID 30610410›Full record

ArticleJournal of industrial microbiology & biotechnology2019

Fabclavine biosynthesis in X. szentirmaii: shortened derivatives and characterization of the thioester reductase FclG and the condensation domain-like protein FclL.

Sebastian L Wenski, Diana Kolbert, Gina L C Grammbitter, Helge B Bode

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Structure and biosynthesis of deoxy-polyamine in Xenorhabdus bovienii.Journal of industrial microbiology & biotechnology · 2021
    Article
  10. Article
  11. Review
  12. Fabclavine diversity inBeilstein journal of organic chemistry · 2020
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sebastian L WenskiMolekulare Biotechnologie, Fachbereich Biowissenschaften, Goethe Universität Frankfurt, 60438, Frankfurt, Germany.
Diana KolbertMolekulare Biotechnologie, Fachbereich Biowissenschaften, Goethe Universität Frankfurt, 60438, Frankfurt, Germany.
Gina L C GrammbitterMolekulare Biotechnologie, Fachbereich Biowissenschaften, Goethe Universität Frankfurt, 60438, Frankfurt, Germany.
Helge B BodeMolekulare Biotechnologie, Fachbereich Biowissenschaften, Goethe Universität Frankfurt, 60438, Frankfurt, Germany. h.bode@bio.uni-frankfurt.de.ORCID http://orcid.org/0000-0001-6048-5909

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fabclavines, unusual peptide-polyketide-polyamine hybrids, show broad-spectrum bioactivity against a variety of different organism like Gram-positive and -negative bacteria, fungi and protozoa. We elucidated the biosynthesis of these NRPS-PKS hybrids in Xenorhabdus szentirmaii by deletion of most genes encoded in the fabclavine BGC and subsequent analysis of produced fabclavine or polyamine intermediates. Thereby, we identified shortened fabclavines similar to the bioactive zeamines. Furthermore, we analyzed the thioester reductase FclG and the free-standing condensation domain-like protein FclL in detail and observed low substrate specificity for both enzymes.

Indexed as

Bacterial ProteinsBiosynthetic PathwaysGene DeletionGenes, BacterialOligopeptidesOxidoreductasesPolyaminesSubstrate SpecificityXenorhabdusBacterial ProteinsOligopeptidesOxidoreductasesPolyaminesAntibioticFabclavineNatural product biosynthesisNRPS–PKS hybridXenorhabdus

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.